We are live on ! Find out more
INGN icon

Inogen

127 hedge funds and large institutions have $138M invested in Inogen in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 48 increasing their positions, 45 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.37% more ownership

Funds ownership: 70.88%73.25% (+2.4%)

7% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 45

3% more capital invested

Capital invested by funds: $134M → $138M (+$4.4M)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

1% less funds holding

Funds holding: 128127 (-1)

Holders
127
Holders Change
-1
Holders Change %
-0.78%
% of All Funds
1.67%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
15
Increased
48
Reduced
45
Closed
15
Calls
$128K
Puts
Net Calls
+$128K
Net Calls Change
-$7K

INGN Hedge Fund Activity: Q2 2025 in Review

127 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q2 2025, worth a combined $138M — up 3.3% from $134M a quarter earlier.

Fund positioning in INGN was balanced in Q2 2025: 15 funds opened new positions, 15 closed out, 48 added to existing stakes and 45 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $4.47M. The largest seller was Bridgeway Capital Management, cutting an estimated $1.58M.

  • 127 institutional investors held Inogen (INGN) as of Q2 2025, down from 128 in Q1 2025.
  • Funds reported $138M of Inogen stock for Q2 2025, up 3.3% quarter-over-quarter.
  • 15 funds opened new Inogen positions in Q2 2025 and 15 closed out, a net change of 0 holders.
  • The largest Inogen buyer in Q2 2025 was Armistice Capital, an estimated $4.47M added.
  • The largest Inogen seller in Q2 2025 was Bridgeway Capital Management, an estimated $1.58M sold.

Based on aggregated 13F filings for Q2 2025.